Clinical Trial Update: Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI) [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of Phase 1/2 clinical trials evaluating Ilomedin (iloprost) in patients who have undergone primary percutaneous coronary inter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Ilomedin (iloprost)

Snippet

Sponsor: Thrombologic ApS | Conditions: Myocardial Infarct | Phase 1, Phase 2 | Status: COMPLETED